Navigation Links
Cardica's Cardiac Anastomosis Device Featured in Clinical Presentation on Robotic Cardiac Bypass Procedures
Date:9/9/2011

REDWOOD CITY, Calif., Sept. 9, 2011 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today reported that its C-Port® Flex-A® Anastomosis System will be featured in a clinical presentation to cardiothoracic surgeons this afternoon at the East Carolina Heart Institute-International Society for Minimally Invasive Cardiothoracic Surgery (ECHI-ISMICS) Summit in Greenville, North Carolina. The presentation, entitled "Robotic Coronary Revascularization: Connectors and Pearls," will be given by nationally-renowned cardiothoracic surgeon, Husam Balkhy, M.D., director of the Center for Robotic and Minimally Invasive Cardiac Surgery at The Wisconsin Heart Hospital, Milwaukee, Wisconsin.

"Dr. Balkhy has been using our anastomosis systems to attach the bypass graft vessels during minimally invasive cardiac surgery, for many years, with remarkable success," said Bernard A. Hausen, M.D., Ph.D., president and chief executive officer of Cardica, Inc. "This presentation offers other cardiothoracic surgeons the opportunity to see first-hand the difference between a connector bypass procedure using our automated anastomosis device compared to hand-sewing the anastomosis."

The presentation details how Dr. Balkhy uses Cardica's C-Port systems to perform a connector procedure, including selection of graft vessels, a description of the features and benefits of the C-Port system, and the mechanics of deployment during connector procedures on a beating heart in the closed chest setting, also known as a totally endoscopic coronary artery bypass (TECAB) procedure. In addition, Dr. Balkhy's use of the C-Port systems is described in the current peer-reviewed issue of The Annals of Thoracic Surgery in an article entitled "Integrating Coronary Anastomotic Connectors and Robotics Toward a Totally Endoscopic Beating Heart Approach: Review of 120 Cases." Dr. Balkhy is a recognized expert in the field of minimally invasive and robotic cardiothoracic surgery and has pioneered the connector procedure. He has trained physicians around the world on his technique using Cardica's C-Port Flex-A System.  

About Cardica

Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System, for coronary artery bypass graft (CABG) surgery and has shipped over 36,000 units throughout the world. In addition, Cardica is developing the Cardica MicroCutter XPRESS™ 30, a true multi-fire laparoscopic stapling device designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter products require 510(k) review and are not yet commercially available in the U.S.

Forward-Looking Statements

This press release contains "forward-looking" statements, including all statements regarding the performance of the C-Port Systems during robotic cardiac bypass procedures. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "offers," "intended" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including that Cardica's current and any future products may never gain any significant degree of market acceptance; that any future Cardica products face development, regulatory, reimbursement and manufacturing risks; that Cardica's intellectual property rights may not provide adequate protection; that Cardica's sales, marketing and distribution strategy and capabilities may not be sufficient or successful; and that general business and economic conditions may impair Cardica's ability to market and develop products, as well as other risks detailed from time to time in Cardica's reports filed with the U.S. Securities and Exchange Commission, including its Quarterly Report filed on for 10-Q. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read Cardica's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.


'/>"/>
SOURCE Cardica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD® and ResQPump™) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest
2. Philips Unveils a Vision for the Future of Cardiac Care at ESC 2011
3. India Cardiac Catheters and Guidewires - Market Trends Till 2016
4. China Cardiac Catheters and Guidewires - Market Trends Till 2016
5. JHP Pharmaceuticals to Produce Clinical Batches of Innovative Cardiac Drug
6. Cardiac Science Expands Device Connectivity Solutions
7. OrbusNeichs Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery
8. Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED
9. Reportlinker Adds US Cardiac Assist Devices -- Market Trend Till 2016
10. Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.
11. Reportlinker Adds European Markets for Cardiac Surgery Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 2017  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. ... of directors: Christopher Gabrieli ... serve as chairman of the board of Akcea Therapeutics. ... of Forest Laboratories. Sandford D. Smith ... "We are excited to announce this expansion to ...
(Date:3/28/2017)... SAN FRANCISCO , March 28, 2017 ... market  is expected to reach a value of USD ... by Grand View Research, Inc. Proper closure of injured ... tissue,s structure and function. Postoperative leakages occur in 3% ... serious complication. They are responsible for one third of ...
(Date:3/27/2017)... The National University of Singapore (NUS) ... company, signed a Memorandum of Understanding (MOU) recently ... the region. Under this MOU, ... Technology (BIGHEART) at NUS and Holmusk will establish ... healthcare IT and medical device development. These include ...
Breaking Medicine Technology:
(Date:3/28/2017)... Wethersfield, Conn. (PRWEB) , ... March 28, 2017 ... ... company based in Wethersfield, Conn., has relocated its corporate headquarters to a new, ... and clients. , In October 2016, Qualidigm purchased a distressed office building ...
(Date:3/28/2017)... Petersburg Florida (PRWEB) , ... March 28, 2017 , ... ... Marine Corp to raise money to for the Toys for Tots Literacy Campaign at ... federal budget in excess of $70 billion, the U.S. ranks at number 14 internationally ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to earn placements ... channels. , While many results are clear, much of PR is hard to quantify. ... it comes to measurement, firms should always take an all-inclusive approach that takes both ...
(Date:3/28/2017)... ... , ... Thank you to all who attended Capio Partners Winter 2017 Healthcare ... exclusive to providers and offered an opportunity to collaborate and network with healthcare colleagues ... Hyatt where attendees gathered for a lively discussion on trends and issues that healthcare ...
(Date:3/27/2017)... ... March 27, 2017 , ... The respected dental team at ... teeth without the extensive time commitment and aesthetic disadvantages of traditional braces can ... A custom-designed series of virtually invisible aligners are created for each patient and ...
Breaking Medicine News(10 mins):